Maine has joined twenty-three (23) other Attorneys General formerly opposed to Purdue Pharma’s $38 million dollar bonuses for company executives. The AG filed a joinder to the US Trustee’s objection to Purdue’s authorization request for their multi-million dollar incentive, bonuses and severance plans.
Purdue made this request just two weeks after declaring bankruptcy in the face of multi-billion dollar liabilities for their role in engineering the opioid epidemic.
“These bonuses are yet another example of how Purdue’s executives, including the Sackler family, continue to seek to profit from the opioid crises,” said Attorney General Aaron M. Frey. “We strongly object to these bonuses and will continue our efforts in Maine’s courts to hold them accountable for their actions.”
The Sackler defendants increased the companies sales force nationally and in Maine which enabled them to increase their visits to Maine health providers. As a consequence of the increased sales visits, sales of Purdue’s opioid rose in Maine and in 2012 Maine health care prescribers wrote prescriptions for long-acting/extended-release opioid pain relievers – the type Purdue sells at the highest rate in the nation: 21.8 prescriptions per 100 Mainers.